LncRNA ‐ ATB Orchestrates Tumor Growth and Immune Responses Through the Modulation of IGF2BP2 in Non‐Small‐Cell Lung Cancer
- 15 July 2026
- journal article
- research article
- Published by Wiley in IUBMB Life
- Vol. 78 (7) , e70085
Abstract
Long non‐coding RNAs (lncRNAs) are known to play a vital role in regulating tumorigenesis. Previous studies have shown that long non‐coding RNA modulated by transforming growth factor‐beta (lncRNA‐ATB) is overexpressed in non‐small‐cell lung cancer (NSCLC); however, the underlying mechanism of lncRNA‐ATB as an oncogenic regulator remains elusive. This study elucidates the effect of lncRNA‐ATB on cell proliferation, migration, and invasion of NSCLC cell lines (A549 and H522) and triggers cellular immune responses. The tumor microenvironment was simulated in BALB/c mice, and the in vivo pro‐tumor effect of lncRNA‐ATB was discovered. This study further explores the molecular mechanisms of lncRNA‐ATB‐mediated effects. The interaction of lncRNA‐ATB with insulin‐like growth factor 2 mRNA‐binding proteins (IGF2BPs) has been found, and IGF2BP2 can play a role in tumor immune cell infiltration and tumor cell proliferation by stabilizing lncRNA‐ATB. In conclusion, lncRNA‐ATB plays a complex regulatory role in the progression of NSCLC and may serve as a potential target for future treatment. This study provides valuable insights into the complex interactions of lncRNAs in the pathogenesis of NSCLC, and the robust methodology and comprehensive analysis presented in this study contribute to advancing our understanding of the molecular mechanisms underlying NSCLC progression.Keywords
Funding Information
- Natural Science Foundation of Ningbo Municipality (2023J157)
- Natural Science Foundation of Ningbo Municipality (2018A610205)
This publication has 53 references indexed in Scilit:
- IGF2BP2 Drives Cell Cycle Progression in Triple‐Negative Breast Cancer by Recruiting EIF4A1 to Promote the m6A‐Modified CDK6 Translation Initiation ProcessAdvanced Science, 2023
- Decoding hepatocarcinogenesis from a noncoding RNAs perspectiveJournal of Cellular Physiology, 2023
- Long non‐coding RNA ATB expedites non‐small cell lung cancer progression by the miR‐200b/fibronectin 1 axisJournal of Clinical Laboratory Analysis, 2023
- N6-methyladenosine-modified circular RNA QSOX1 promotes colorectal cancer resistance to anti-CTLA-4 therapy through induction of intratumoral regulatory T cellsDrug Resistance Updates, 2022
- m6A modification of lncRNA PCAT6 promotes bone metastasis in prostate cancer through IGF2BP2‐mediated IGF1R mRNA stabilizationClinical and Translational Medicine, 2021
- Long noncoding RNAs in cancer‐immunity cycleJournal of Cellular Physiology, 2018
- Long non-coding RNA-ATB promotes EMT during silica-induced pulmonary fibrosis by competitively binding miR-200cBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2018
- High expression of long non-coding RNA ATB indicates a poor prognosis and regulates cell proliferation and metastasis in non-small cell lung cancerClinical and Translational Oncology, 2016
- Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression?Cellular and Molecular Life Sciences, 2012
- Effect of obesity and glycemic control on serum lipocalins and insulin-like growth factor axis in type 2 diabetic patientsActa Diabetologica, 2012